Commercialisation Awards - The Bloomsbury Set

COMMERCIALISATION AWARDS

Supporting projects that are beyond early-stage commercialisation, these projects were selected by a panel of industry experts based on their translational potential for commercial applications. Each project was awarded £100,000 for the duration of a year.

An antimalarial drug targeting Plasmodium phosphodiesterases to cure patients and block transmission; a new tool to combat drug resistance

Dr David Baker (LSHTM), Dr Mark Gardner (Salvensis), Dr Alan Brown (Salvensis), Dr James Duffy (Medicine for Malaria Venture) - £95,216

1 April 2020 to 28 February 2021 (Commercialisation Award BSA35)

Development of an inactivated oral yeast vaccine against poultry Eimeria

Prof Damer Blake (RVC), Prof Fiona Tomley (RVC), Prof Dirk Werling (RVC), Dr Francesca Soutter (RVC), Dr Matthew Nolan (Cambridge University), Dr Tatiana Küster (Universität Bern) - £91,479

1 March 2020 to 28 February 2021 (Commercialisation Award BSA36)

Antimicrobial eye drops with extended duration of effect and efficicacy

Prof Liam Good (RVC / Tecrea Ltd), Dr Winnie Ntowboahene (RVC), Chiara Febrarro (Tecrea Ltd), David Cook (Tecrea Ltd), John Ridden (Tecrea Ltd) - £99,939

1 March 2020 to 28 February 2021 (Commercialisation Award BSA38)

Malaria Detection Dogs

Prof James Logan (LSHTM), Prof Steve Lindsay (Durham University), Clare Guest (Medical Detection Dogs) - £95,822

1 March 2020 to 28 February 2021 (Commercialisation Award BSA39)

Optimising sugar attachment site in vaccine

Dr Jon Cuccui (LSHTM), Prof Brendan Wren (LSHTM) - £71,011

1 March 2020 to 28 February 2021 (Commercialisatio Award BSA37)